A summit attended by healthcare experts and representatives from the National Institutes of Health (NIH), American Cancer Society, the American Society for Cancer Research (ASCR), and American Society of Clinical Oncology (ASCO) convened, producing a list of recommendations to extend better cancer screening and care to currently underserved minority populations. Among the recommendations is to include minority health care teams in clinical trial design; include sustainability plans for maintaining community relationships; and ensure that major cancer initiatives include sufficient representation from minority populations. The hope is that through these recommendations, screening and treatment can benefit all populations, regardless of race, ethnicity or economic status. http://bit.ly/2vsJhNn
- How can our society study and regulate the offerings of popular, but unproven, regenerative medicine?
- One patient’s story: How WCGF helped speed approval for experimental treatment
- How did physicians use a discovery from a recent #clinicaltrial to save the life of a boy with a dangerous skin condition?
- How is the FDA widening the scope of the Reagan Udall Expanded Access Navigator to assist patients with rare or orphan diseases?
- How can you further WCGF’s mission to educate, include and provide access?